Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Time-Restricted Eating as a Potential Strategy to Promote Weight Loss Maintenance in Patients With Obesity (REGANE)

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

While body weight reduction can be achieved through various interventions in people living with obesity, most patients regain a substantial proportion of the lost weight within the following months. There is a lack of effective interventions to prevent this regain, making weight regain one of the most pressing challenges in obesity management. The goal of this clinical trial is to determine whether adhering to time-restricted eating (TRE; a form of intermittent fasting) during and after a dietary weight loss intervention, promotes weight maintenance to a greater extent than consuming all daily meals within 12 hours or more. Additionally, the study will address other questions, such as whether TRE improves body composition, insulin sensitivity, and cardiometabolic risk factors; whether the TRE intervention produces effects on different components of energy balance or related behaviors; and whether prior exposure to the TRE intervention influences eating window duration and weight change over the subsequent 24 months. The study will compare participants who concentrate all their food intake within 8 hours or less with those who consume all their daily meals within 12 hours or more. All participants will follow a calorie-restricted diet designed to induce an 8-10% weight loss over 12-16 weeks and will be followed for several months after the weight loss intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Have a body mass index of 30-45 kg/m2.

• Have safety laboratory test results (general biochemistry and complete blood count) within the normal reference range or with abnormalities considered clinically insignificant by the medical research team and that do not require the initiation of drug treatment.

• Have sufficient venous access for the blood sampling required by the procedures described in this protocol, and not have a phobia of needles or blood.

• Maintain a usual intake window of 12 hours or longer at least 5 days a week and have a response rate greater than 85% during the self-recording carried out during the screening process.

• Willingness and ability to consume all foods provided during the outcome assessment and dietary intervention.

• Being able to understand and undergo the procedures that are part of the study, in the opinion of the research team.

• Availability to participate in the study.

• Be willing to complete the study regardless of the group to which they are assigned.

Locations
Other Locations
Spain
Department of Physiology, Faculty of Medicine, University of Granada.
RECRUITING
Granada
Contact Information
Primary
Guillermo Sanchez-Delgado
gsanchezdelgado@ugr.es
+34 958241574
Time Frame
Start Date: 2025-12-18
Estimated Completion Date: 2030-06
Participants
Target number of participants: 212
Treatments
Experimental: Time-restricted eating (eating within 8 hours/day or less)
Participants in the time-restricted eating group will be instructed to concentrate all daily meals to 8 hours or less
Sham_comparator: Regular eating window (eating within 12 hours/day or more)
Participants in the regular eating group will be instructed to spread all daily meals within a of 12 hours or more.
Related Therapeutic Areas
Sponsors
Collaborators: Hospital Clinico Universitario San Cecilio, University Hospital Virgen de las Nieves
Leads: Universidad de Granada

This content was sourced from clinicaltrials.gov